Professional and technical services blanket purchase agreement (BPA)
Ended Awarded Last action
- Contract number
- 75F40121F19196
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $27,791
Award facts
- Contract value 25% obligated
-
- $27,790.57 Current, with exercised options
- $110,885.65 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$38,987 | |
| Supplemental Agreement for work within scope | $11,195 | |
| Other Administrative Action | $0 | |
| Original award | $55,582 |
About this award
This is a Blanket Purchase Agreement (BPA) awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Brillient Corporation, a management, technology, and business process management firm. The BPA, which is not set aside, is for professional and technical services with a potential value of $110,885.65 and a period of performance through December 26, 2023. The BPA was awarded under the Multiple Award Schedule (MAS) contract vehicle, allowing Brillient to provide a range of services to the FDA, including program management, IT services, engineering, consulting, and administrative support. Brillient is a minority-owned, Subchapter S Corporation that has experience delivering various goods and services as a prime contractor to federal agencies such as HHS, DHS, Treasury, and NIH.
Quick answers
Who was awarded contract 75F40121F19196?
75F40121F19196 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on September 23, 2021.
How much is contract 75F40121F19196 worth?
The government has obligated $27,791 on 75F40121F19196. Its potential value, with all options, is $110,886.
Is contract 75F40121F19196 an order under another contract?
Yes. 75F40121F19196 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19196 competed?
The extent of competition for 75F40121F19196 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award